Clinical Trial Update: Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of Xaluritamig in adults with metastatic castration-resistant prostate cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Xaluritamig (Xaluritamig)

Snippet

Sponsor: Amgen | Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 1 | Status: NOT_YET_RECRUITING